EI
AXSM icon

Ellevest Inc’s Axsome Therapeutics AXSM Stock Holding History

Ellevest Inc’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-58
Closed -$2K – 1399
2022
Q1 		$2K Sell
58
-7
-11% -$217 ﹤0.01% 1173
2021
Q4 		$2K Hold
65
– – ﹤0.01% 1138
2021
Q3 		$2K Buy
65
+48
+282% +$1.87K ﹤0.01% 1105
2021
Q2 		$1K Buy
+17
New +$1.02K ﹤0.01% 1120
2020
Q4 		– Sell
-1
Closed – – 1191
2020
Q3 		$0 Sell
1
-10
-91% -$779 ﹤0.01% 1137
2020
Q2 		$1K Buy
+11
New +$847 ﹤0.01% 955

Other funds holding AXSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Ellevest Inc's AXSM Position: Q2 2022 in Review

Ellevest Inc sold out of Axsome Therapeutics (AXSM) in Q2 2022, closing a stake of 58 shares — an estimated $2K sold.

Ellevest Inc first reported a position in AXSM in Q2 2020 and held it in 6 quarters. The position peaked at $2K in Q1 2022. 174 funds tracked by Wall St. Rank hold AXSM as of Q2 2022.

  • Ellevest Inc reported no remaining Axsome Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Ellevest Inc sold 58 Axsome Therapeutics shares in Q2 2022, an estimated $2K.
  • Ellevest Inc first reported a position in Axsome Therapeutics in Q2 2020 and held it in 6 quarters.
  • Ellevest Inc's Axsome Therapeutics position peaked at $2K in Q1 2022.
  • 174 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2022.

Based on Ellevest Inc's 13F filing for Q2 2022, filed 18 Jul 2022.